Multiple sclerosis MS is an autoimmune disease characterized by multifocal white matter lesions (WMLs), the so-called MS plaques (Popescu et al., 2013)
"In ordinary circumstances, I would say that these products are dead," Peter Lurie, president of the Center for Science in the Public Interest and a former FDA official, told AFP
It is evidence-based injury management that applies whether BPC-157 is being used or not, and it applies more urgently precisely because BPC-157 removes the pain signal that would otherwise enforce appropriate rest
Another drug, activated protein C, reduces BBB breakdown and leakage in stroke model rodents and has anti-inflammatory effects, neuroprotective effects, and blocks hemorrhage after brain ischemia [126, 127]